Received May 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
The patient was administered the one vial prep of menveo instaed of two vials prep. No adversed events wee observed or reported following administration, upon identification of the variance, the event was documented and the care team was notified.
unknown
unknown
unknown
unknown
none